Steroid-sensitive Nephrotic Syndrome
📧 Sign up to get email alerts when something new happens for Steroid-sensitive Nephrotic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome [Phase 4]
Clinical trial evaluating atorvastatin for dyslipidemia in children with steroid-sensitive nephrotic syndrome; Phase 4 study now completed.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome [Phase 1]
Phase 1 trial evaluating the safety and potential efficacy of azithromycin to achieve remission in children with steroid-sensitive nephrotic…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome [NA]
The study reports on whether zinc supplementation can help maintain sustained remission in children with steroid-sensitive nephrotic syndrom…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Rituximab in the First Episode of Paediatric Nephrotic Syndrome [Phase 3]
A Phase 3 clinical trial evaluating rituximab for first-episode steroid-sensitive nephrotic syndrome in pediatric patients; currently not ye…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome [Phase 2, Phase 3]
A phase 2/3 trial comparing obinutuzumab to rituximab in children with steroid-dependent or frequently relapsing nephrotic syndrome is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome [Phase 2]
Phase 2 trial assessing rituximab for efficacy and safety in first episode pediatric steroid-sensitive nephrotic syndrome has completed.
-
CLINICAL_TRIALS withdrawal · 2020-12-17Clinical Trial Update: Study of Initial Steroid Treatment in Young Children With Nephrotic Syndrome [Phase 3]
Phase 3 trial evaluating initial steroid treatment in young children with steroid-sensitive nephrotic syndrome has been withdrawn.